Mabthera and disease progression 
Mabthera and disease progression Patient Reports March 20, 2010
Mabthera Side Effects Report #5172574-7
Mabthera side effect was reported by a Physician from GERMANY on Nov 20, 2006. Male patient, 66 years of age, weighting 220.5 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bladder disorder, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, cd4 lymphocytes decreased, disease progression, herpes zoster multi-dermatomal, infection in an immunocompromised host, lymphangiectasia. Mabthera dosage: unknown. During the same period patient was treated with EDRONAX, STANGYL, TAMSULOSIN, DIPIPERON, FOLIC ACID, CLINDAMYCIN, CYCLOPHOSPHAMIDE, LIPOSOMAL DOXORUBICIN. Patient recovered.
Mabthera Side Effects Report #4613248-8
Mabthera side effect was reported by a Physician from on Feb 28, 2005. Male patient, 66 years of age, weighting 220.5 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anorectal disorder, antibody test abnormal, bladder disorder, blood immunoglobulin a decreased, blood immunoglobulin g decreased, cd4 lymphocytes decreased, disease progression, infection in an immunocompromised host, lymphopenia. Mabthera dosage: unknown. During the same period patient was treated with EDRONAX, STANGYL, OMNIC, DIPIPERON, FOLIC ACID, SOBELIN, CYCLOPHOSPHAMIDE, LIPOSOMAL DOXORUBICIN. Patient recovered.
Mabthera Side Effects Report #4640596-8
Mabthera side effect was reported by a Physician from on Apr 07, 2005. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: confusional state, disease progression, incontinence, mobility decreased, pneumonia
, supranuclear palsy. Mabthera dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5344361-8
Mabthera side effect was reported by a Physician from UNITED STATES on May 24, 2007. Female patient was diagnosed with vasculitis
, pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.Mabthera Side Effects Report #5866006-0
Mabthera side effect was reported by a Physician from UNITED STATES on Aug 21, 2008. Female patient was diagnosed with vasculitis
, pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.Mabthera Side Effects Report #5914990-9
Mabthera side effect was reported by a Physician from ITALY on Oct 02, 2008. Female patient was diagnosed with vasculitis
, pain and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.Mabthera Side Effects Report #6135778-2
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Mar 13, 2009. Male patient, 39 years of age, was diagnosed with systemic lupus erythematosus, immunosuppression and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, hepatitis fulminant. Mabthera dosage: unknown. During the same period patient was treated with PREDNISONE, FELODIPINE, OMEPRAZOLE, ACETYLSALICYLIC ACID SRT, MYCOPHENOLATE MOFETIL. Patient died.
Mabthera Side Effects Report #4968764-6
Mabthera side effect was reported by a Physician from ITALY on Mar 23, 2006. Male patient, 70 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, non-hodgkin's lymphoma, sepsis
, shock. Mabthera dosage: 700 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE, FLUDARABINE, DECADRON. Patient died on 08/03/2005.Mabthera Side Effects Report #4649844-1
Mabthera side effect was reported by a Health Professional from on Apr 19, 2005. Male patient, 68 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, parkinson's disease
. Mabthera dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL, ACETAMINOPHEN, SELOKEEN, PREDNISONE, MOVICOLON. Patient recovered.Mabthera Side Effects Report #4659362-2
Mabthera side effect was reported by a Health Professional from on Apr 28, 2005. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: back pain
, disease progression, febrile neutropenia, intervertebral disc protrusion, lymphoma , multi-organ failure, pain in extremity, pancytopenia, sepsis . Mabthera dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, YTRACIS, FILGRASTIM, CEFTRIAXONE, CLINDAMYCIN HYDROCHLORIDE, LEVOFLOXACIN, FLUCONAZOLE. Patient died.Mabthera Side Effects Report #4618486-6
Mabthera side effect was reported by a Physician from on Mar 08, 2005. Female patient, 52 years of age, weighting 128.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, leukocytosis, nerve root compression, non-hodgkin's lymphoma. Mabthera dosage: 654 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, HYDROMORPHONE, GABAPENTIN, FRAGMIN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4783753-2
Mabthera side effect was reported by a Physician from EL SALVADOR on Sept 13, 2005. Male patient, 42 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute abdomen, disease progression, non-hodgkin's lymphoma, pancytopenia, sepsis
. Mabthera dosage: unknown. During the same period patient was treated with VINCRISTINE, DEXAMETHASONE, DAUNORUBICIN HYDROCHLORIDE. Patient died on 08/02/2005.Mabthera Side Effects Report #4788893-X
Mabthera side effect was reported by a Physician from EL SALVADOR on Sept 21, 2005. Male patient, 42 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute abdomen, disease progression, non-hodgkin's lymphoma, pancytopenia, sepsis
. Mabthera dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, ETOPOSIDE, EPIRUBICIN, DEXAMETHASONE. Patient died on 08/02/2005.Mabthera Side Effects Report #4629461-X
Mabthera side effect was reported by a Health Professional from on Sept 08, 2004. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: abscess
, cellulitis , disease progression, metastases to gastrointestinal tract, metastases to ovary, nosocomial infection, oedema, pneumonia , respiratory failure. Mabthera dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 09/03/2004.Mabthera Side Effects Report #4635620-2
Mabthera side effect was reported by a Health Professional from on Mar 31, 2005. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, parkinson's disease
. Mabthera dosage: unknown. Patient recovered.Mabthera Side Effects Report #4978808-3
Mabthera side effect was reported by a Physician from GERMANY on Apr 03, 2006. Male patient, 68 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, respiratory distress. Mabthera dosage: unknown. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4985984-5
Mabthera side effect was reported by a Physician from GERMANY on Apr 03, 2006. Male patient, 68 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, respiratory distress. Mabthera dosage: unknown. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5899244-1
Mabthera side effect was reported by a Physician from UNITED STATES on Sept 18, 2008. Male patient, weighting 142.2 lb, was diagnosed with lymphoma
, anxiety and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Mabthera dosage: 375 MG/M2, Q2W. During the same period patient was treated with NEULASTA, OXALIPLATIN, GEMCITABINE, MESNA, IFOSFAMIDE, NOVANTRONE, ETOPOSIDE, ANTIANXIETY AGENT NOS. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #6023403-0
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 16, 2008. Male patient, 78 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, multi-organ failure, progressive multifocal leukoencephalopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, RESPRIMTE, OMEPRAZOLE. Patient was hospitalized. Patient died.
Mabthera Side Effects Report #4556897-8
Mabthera side effect was reported by a Physician from on Jan 06, 2005. Female patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acidosis, anaemia, bacterial sepsis, disease progression, disseminated intravascular coagulation, laboratory test abnormal, neutropenia, platelet count decreased, tachypnoea. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTOSINE ARABINOSIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/25/2004.
Mabthera Side Effects Report #4595333-2
Mabthera side effect was reported by a Physician from on Feb 08, 2005. Female patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acidosis, anaemia, bacterial sepsis, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, neutropenic sepsis, tachypnoea, white blood cell count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTOSINE ARABINOSIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/29/2004.
Mabthera Side Effects Report #5938212-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 21, 2008. Female patient, 60 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, HYDROXYDAUNORUBICIN, ONCOVIN, PREDNISONE. Patient died on 10/06/2008.
Mabthera Side Effects Report #5024309-6
Mabthera side effect was reported by a Physician from GERMANY on May 25, 2006. Female patient, 43 years of age, was diagnosed with dermatomyositis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardiac failure, dermatomyositis, disease progression, off label use, vasculitis
. Mabthera dosage: unknown. Patient recovered.Mabthera Side Effects Report #5775846-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on June 03, 2008. Female patient was diagnosed with cryoglobulinaemia, infection prophylaxis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion. Mabthera dosage: 600 MG, UNK. During the same period patient was treated with BACTRIM, MEDROL. Patient died.
Mabthera Side Effects Report #5985094-4
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Nov 24, 2008. Female patient, 77 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia refractory, disease progression, malignant neoplasm progression, no therapeutic response. Mabthera dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, FLUDARABINE PHOSPHATE, CHLORAMBUCIL. Patient died.
Mabthera Side Effects Report #5987858-X
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Nov 24, 2008. Female patient, 77 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression. Mabthera dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, FLUDARABINE PHOSPHATE, CHLORAMBUCIL. Patient died.
Mabthera Side Effects Report #5987105-9
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Nov 24, 2008. Male patient, 67 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CHLORAMBUCIL, FLUDARABINE PHOSPHATE, ALEMTUZUMAB, CYCLOPHOSPHAMIDE. Patient died.
Mabthera Side Effects Report #5304774-7
Mabthera side effect was reported by a Physician from GERMANY on Apr 11, 2007. Male patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: arthralgia, borrelia burgdorferi serology negative, borrelia infection, disease progression, facial paresis, gamma-glutamyltransferase increased, haemoglobin decreased, hyperaesthesia, lymphoma
. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.Mabthera Side Effects Report #5023209-5
Mabthera side effect was reported by a Physician from GERMANY on May 24, 2006. Male patient, 63 years of age, weighting 187.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood bilirubin increased, disease progression, granuloma, haemolytic anaemia, muscle abscess, neutropenia, pancytopenia, pneumonia
, sepsis . Mabthera dosage: 787 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, ASPIRIN, DIOVAN HCT, MORPHINE, ACETAMINOPHEN, PREDNISONE, ALLOPURINOL. Patient was hospitalized. Patient died on 03/18/2006.Mabthera Side Effects Report #4659363-4
Mabthera side effect was reported by a Pharmacist from on Apr 27, 2005. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: colitis, disease progression, haematocrit decreased, leukopenia, proctitis ulcerative, pyrexia, weight decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, NEUPOGEN, PANTOZOL, DIFLUCAN, CIPROFLOXACIN, ACICLOVIR. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4590100-8
Mabthera side effect was reported by a Health Professional from on Feb 02, 2005. Female patient, 79 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bradycardia, clostridium colitis, dehydration, disease progression, hypotension, hypoxia, neutropenia, pleural effusion, pneumonia
. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 01/23/2005.Mabthera Side Effects Report #4673992-3
Mabthera side effect was reported by a Physician from on May 09, 2005. Female patient, 79 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bradycardia, clostridium colitis, dehydration, disease progression, disease recurrence, dyspnoea, hypotension, hypoxia, neutropenia. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 01/23/2005.
Mabthera Side Effects Report #5365598-8
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 05, 2007. Male patient, weighting 176.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: coma, disease progression, respiratory failure. Mabthera dosage: unknown. Patient died.
Mabthera Side Effects Report #5761936-2
Mabthera side effect was reported by a Pharmacist from UNITED KINGDOM on May 27, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, guillain-barre syndrome
. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISOLONE. Patient recovered.Mabthera Side Effects Report #4603631-9
Mabthera side effect was reported by a Health Professional from on Feb 23, 2005. Male patient, 75 years of age, weighting 200.6 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blood albumin increased, crepitations, disease progression, malaise, neutropenic sepsis, oedema. Mabthera dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4629407-4
Mabthera side effect was reported by a Health Professional from on Mar 29, 2005. Male patient, 75 years of age, weighting 200.6 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, blood albumin increased, crepitations, disease progression, neutropenic sepsis, oedema, unevaluable event. Mabthera dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.